Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Maintains Equal-Weight on ADC Therapeutics, Lowers Price Target to $5

Morgan Stanley analyst Matthew Harrison maintains ADC Therapeutics (NYSE:ADCT) with a Equal-Weight and lowers the price target from $7 to $5.

byBenzinga Newsdesk

January 24, 2023

1 minute read

Morgan Stanley analyst Matthew Harrison maintains ADC Therapeutics (NYSE:ADCT) with a Equal-Weight and lowers the price target from $7 to $5.

Snoop Dogg To Make Death Row Records First NFT Music Label: Report

By Samyuktha Sriram

Today, 10:19 PM

After selling $50 million worth of NFTs in a week, American rapper Snoop Dogg is planning the first NFT music label.

ETH

Analyst Ratings

Analyst Ratings For Floor & Decor Hldgs

By Benzinga Insights

Today, 10:19 PM

Over the past 3 months, 6 analysts have published their opinion on Floor & Decor Hldgs (NYSE:FND) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

FND

Analyst Ratings

Expert Ratings For Comerica

By Benzinga Insights

Today, 10:19 PM

Analysts have provided the following ratings for Comerica (NYSE:CMA) within the last quarter:

CMA

Northland Capital Markets Initiates Coverage On SC Health with Outperform Rating, Announces Price Target of $20

By Benzinga Newsdesk

Today, 10:19 PM

Northland Capital Markets analyst Tim Savageaux initiates coverage on SC Health (NYSE:SCPE) with a Outperform rating and announces Price Target of $20.

SCPE

Morgan Stanley Maintains Equal-Weight on ADC Therapeutics, Lowers Price Target to $5

Related Posts

Snoop Dogg To Make Death Row Records First NFT Music Label: Report

Analyst Ratings For Floor & Decor Hldgs

Expert Ratings For Comerica

Northland Capital Markets Initiates Coverage On SC Health with Outperform Rating, Announces Price Target of $20